Evidence map›Paper›PMID 31515279›Full record

ArticleJournal of cell science2019

Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes.

Elizabeth L Zoeller, Brian Pedro, Jessica Konen, Bhakti Dwivedi, Manali Rupji, Niveda Sundararaman, Lei Wang, John R Horton, Chaojie Zhong, Benjamin G Barwick and 6 more

Abstract read
In one paragraph

Article in Journal of cell science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Collective migration modes in development, tissue repair and cancer.Nature reviews. Molecular cell biology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Long noncoding RNA MALAT1 is dynamically regulated in leader cells during collective cancer invasion.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Collective metastasis: coordinating the multicellular voyage.Clinical & experimental metastasis · 2021
    Review
  16. Review
  17. Partial EMT in Squamous Cell Carcinoma: A Snapshot.International journal of biological sciences · 2021
    Review
  18. Review
  19. Collective cancer cell invasion requires RNA accumulation at the invasive front.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Elizabeth L ZoellerGraduate Program in Cancer Biology, Emory University, Atlanta, GA 30322, USA.
Brian PedroGraduate Program in Cancer Biology, Emory University, Atlanta, GA 30322, USA.
Jessica KonenGraduate Program in Cancer Biology, Emory University, Atlanta, GA 30322, USA.
Bhakti DwivediWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Manali RupjiWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Niveda SundararamanSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Lei WangHamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
John R HortonDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chaojie ZhongDepartment of Radiation Oncology, Emory University, Atlanta, GA 30322, USA.
Benjamin G BarwickDepartment of Radiation Oncology, Emory University, Atlanta, GA 30322, USA.
Xiaodong ChengDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Elisabeth D MartinezHamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Matthew P TorresSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Jeanne KowalskiWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Adam I MarcusWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA Paula_Vertino@URMC.Rochester.edu aimarcu@emory.edu.
Paula M VertinoWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA Paula_Vertino@URMC.Rochester.edu aimarcu@emory.edu.ORCID 0000-0001-6165-2019

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Systems analysis of phenotypic switch in control of cancer invasionU54CA209992 · NCI · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2016 to 2021
$10.1M
GENESIS AND CONSEQUENCES OF ABERRANT DNA METHYLATIONR01CA077337 · NCI · EMORY UNIVERSITY · PI VERTINO, PAULA M. · 1998 to 2016
$3.4M
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer S1R01CA201340 · NCI · EMORY UNIVERSITY · PI GILBERT-ROSS, MELISSA, MARCUS, ADAM I. · 2016 to 2020
$2.0M
Histone Lysine deMethylation: Structures, Inhibitions and MechanismsR01GM114306 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHENG, XIAODONG · 2015 to 2018
$1.2M
G gamma N-terminal tails as regulators of G protein signalingR01GM117400 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI TORRES, MATT PHILLIP · 2016 to 2019
$1.2M
Role of lysine methylation in estrogen receptor function and tamoxifen responseF31CA186511 · NCI · EMORY UNIVERSITY · PI ZOELLER, ELIZABETH · 2014 to 2016
$129k
Defining leader cell biology in collective invasionF31CA225049 · NCI · EMORY UNIVERSITY · PI PEDRO, BRIAN ARAM · 2018 to 2020
$108k
NCATS NIH HHS UL1 TR002378NCI NIH HHS F31 CA186511NCI NIH HHS F31 CA225049NCI NIH HHS P30 CA138292NCI NIH HHS P50 CA070907NCI NIH HHS R01 CA077337NCI NIH HHS R01 CA201340NCI NIH HHS U54 CA209992NIGMS NIH HHS R01 GM114306NIGMS NIH HHS R01 GM117400NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

Collective invasion, the coordinated movement of cohesive packs of cells, has become recognized as a major mode of metastasis for solid tumors. These packs are phenotypically heterogeneous and include specialized cells that lead the invasive pack and others that follow behind. To better understand how these unique cell types cooperate to facilitate collective invasion, we analyzed transcriptomic sequence variation between leader and follower populations isolated from the H1299 non-small cell lung cancer cell line using an image-guided selection technique. We now identify 14 expressed mutations that are selectively enriched in leader or follower cells, suggesting a novel link between genomic and phenotypic heterogeneity within a collectively invading tumor cell population. Functional characterization of two phenotype-specific candidate mutations showed that ARP3 enhances collective invasion by promoting the leader cell phenotype and that wild-type KDM5B suppresses chain-like cooperative behavior. These results demonstrate an important role for distinct genetic variants in establishing leader and follower phenotypes and highlight the necessity of maintaining a capacity for phenotypic plasticity during collective cancer invasion.

Indexed as

Blotting, WesternCarcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationGenetic HeterogeneityGenomicsHumansLung NeoplasmsMicroscopyNeoplasm InvasivenessRNA-SeqEpigeneticLung cancerMetastasisMutationPlasticityRNA-seq

Identifiers

PMID31515279
PMCPMC6803364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.